TickerFacts.

Mangoceuticals, Inc. (MGRX): Revenue

Annual figures by period end, from SEC filings.

$456.0K
Year ended 2025-12-31
$315.2K
Trailing 12 months to 2026-06-30
n/m
3-year compound annual growth
$731.5K2022-12-31: $8.9K2023-12-31: $731.5K2024-12-31: $615.9K2025-12-31: $456.0K$456.0K
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$456.0K-26.0%2026-04-01, From 2025-01-01
2024-12-31$615.9K-15.8%2026-04-01, From 2024-01-01
2023-12-31$731.5Kn/m2025-03-20, From 2023-01-01
2022-12-31$8.9Kn/a2024-04-01, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31$456.0K-26.0%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$359.7K-10.3%
Charming Medical Ltd (MCTA)2026-03-31$4.81M-22.7%
Pacific Health Care Organization Inc (PFHO)2025-12-31$6.72M+10.7%
Marpai, Inc. (MRAI)2025-12-31$18.10M-35.8%
Cryo Cell International Inc (CCEL)2025-11-30$31.57M-1.3%
Viemed Healthcare, Inc. (VMD)2025-12-31$270.28M+20.5%
Sotera Health Co (SHC)2025-12-31$1.16B+5.7%
Progyny, Inc. (PGNY)2025-12-31$1.29B+10.4%

Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗